Table 2. Endoscopic features in patients with and without sessile gastric polyps.

	Total Patients N = 80 (%)	Patients With Gastric Neoplasm N = 19 (24 %)	Patients Without Gastric Neoplasm N = 61 (76 %)	P value
Fundus/cardia
Polyps present	77 (96.3)	18 (94.7)	59 (96.7)	0.56
# of polyps				0.51
0	4 (5)	0 (0)	4 (6.6)
1–30	12 (15)	4 (21.1)	8 (13.1)
31–50	9 (11.3)	2 (10.5)	7 (11.5)
51–100	18 (22.5)	2 (10.5)	16 (26.2)
> 100	34 (42.5)	10 (52.6)	24 (39.3)
Polyp Size				0.92
1–9 mm	58 (72.5)	15 (78.9)	43 (70.5)
10–19 mm	16 (20)	3 (15.8)	13 (21.3)
≥ 20 mm	1 (1.3)	0 (0)	1 (1.6)
Carpeting	17 (21.3)	5 (26.3)	12 (19.7)	0.53
Polypoid mounds	3 (3.8)	1 (5.3)	2 (3.3)	0.56
White mucosal patch	7 (8.8)	6 (31.6)	1 (1.6)	0.001
Body
Polyps present	75 (93.8)	18 (94.7)	57 (93.4)	0.99
Number of polyps				0.86
0	5 (6.3)	1 (5.3)	4 (6.6)
1–30	12 (15)	4 (21.1)	8 (13.1)
31–50	9 (11.3)	2 (10.5)	7 (11.5)
51–100	16 (20)	2 (10.5)	14 (23)
> 100	33 (41.3)	9 (47.4)	24 (39.3)
Polyp size				0.72
1–9 mm	55 (68.8)	15 (78.9)	40 (65.6)
10–19 mm	17 (21.3)	3 (15.8)	14 (23)
≥ 20 mm	1 (1.3)	0 (0)	1 (1.6)
Carpeting	16 (20)	5 (26.3)	11 (18)	0.43
Mounds	4 (5)	2 (10.5)	2 (3.3)	0.24
White mucosal patch	3 (3.8)	3 (15.8)	0 (0)	0.01
Antrum
Polyps present	6 (7.5)	4 (21.1)	2 (3.3)	0.03
Number of polyps
0	74 (92.5)	59 (96.7)	15 (78.9)	0.02
1–30	4 (5.0)	2 (3.3)	2 (10.5)
31–50	2 (2.5)	0 (0)	2 (10.5)
Polyp size				0.01
1–9 mm	4 (5)	2 (10.5)	2 (3.3)
10–19 mm	2 (2.5)	2 (10.5)	0 (0)
Mounds	0 (0)	0 (0)	0 (0)	0.99
White mucosal patch	0 (0)	0 (0)	0 (0)	0.99
Duodenum
Number of duodenal polyps
0	21 (26.3)	4 (21.1)	17 (27.9)	0.74
1–4	14 (17.5)	4 (21.1)	10 (16.4)
5–20	24 (30)	8 (42.1)	16 (26.2)
> 20	18 (22.5)	3 (15.8)	15 (24.6)
Sizes of polyps in duodenum				0.82
0	21 (26.3)	4 (21.1)	17 (27.9)
1–4 mm	25 (31.3)	8 (42.1)	17 (27.9)
5–10 mm	20 (25)	5 (26.3)	15 (24.6)
> 10 mm	12 (15)	2 (10.5)	10 (16.4)
Spigelman stage				0.68
0	2 (10.5)	0 (0)	2 (10.5)
I	27 (33.8)	7 (36.8)	20 (32.8)
II	32 (40)	9 (47.4)	23 (37.7)
III	16 (20)	2 (10.5)	14 (23)
IV	3 (6.3)	1 (5.2)	2 (4.9)